Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04935463 · ClinicalTrials.gov registry record
Mucormycosis in COVID-19
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 728
- Enrollment target
NCT04935463 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 728 participants.
The verdict
NCT04935463 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 728 participants
- Enrollment target
Study Summary
The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of mucormycosis as it occurs either during the infection or treatment phase of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it is of time sensitive importance to obtain a better understanding of the risk factors and outcomes of this fatal complication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 728 participants |
| Start Date | 2021-05-24 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04935463
The ClinicalTrials.gov registry entry for NCT04935463 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 728 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04935463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04935463 about?
NCT04935463 is a clinical study titled "Mucormycosis in COVID-19". The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of muc...
What is the current status of trial NCT04935463?
This trial is currently completed. The enrollment target is 728 participants. The study started on 2021-05-24. Estimated completion is 2022-03-01.
Who is sponsoring clinical trial NCT04935463?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.